Once outside the body, stored blood begins degrading until, by day 42, they're no longer usable. Until now, assessing its quality has required laborious microscopic examination by human experts. A new study reveals two methodologies that combine machine learning and state-of-the-art imaging to automate the process and eliminate human bias. If standardized, it could ensure more consistent, accurate assessments, with increased efficiency and better patient outcomes.
source https://www.sciencedaily.com/releases/2020/08/200824165630.htm
Tuesday, 25 August 2020
Related Posts
How ‘ice needles’ weave patterns of stones in frozen landscapesExperiments and modeling work offers new insights into the striking pa… Read More
Weighing cancer cells to personalize drug choicesResearchers have developed a new way to determine whether individual p… Read More
Ultra-short flashes of light illuminate a possible path to future beyond-CMOS electronicsResearchers have demonstrated that ultra-short pulses of light, down t… Read More
Toxic fatty acids to blame for brain cell death after injuryCells that normally nourish healthy brain cells called neurons release… Read More
Intelligence emerging from random polymer networksA team of researchers assembled a sulfonated polyaniline (SPAN) organi… Read More
Cancer costs US more than $156 billion annually, with drugs a leading expenseCare for the 15 most prevalent types of cancer in the U.S. cost approx… Read More
0 comments: